Filed 6mo ago· Nov 22, 2025
43 days to disclose
Jared Moskowitz
DHouseFlorida-23
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+4.5% vs S&P 500
Trade dateOct 10, 2025
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Nov 22, 2025 6mo ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Johnson & Johnson JNJ | Oct 10, 2025 43 days to disclose | Flat·+0.0% +4.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 22, 2025 6mo ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Johnson & Johnson JNJ | Oct 10, 2025 43 days to disclose | Flat·+0.0% +4.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 9, 2025 1.1y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Amgen AMGN | Apr 16, 2025 23 days to disclose | Good buy·+$1.4K+17.0% +8.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 9, 2025 1.1y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Amgen AMGN | Apr 16, 2025 23 days to disclose | Good buy·+$1.4K+17.0% +8.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 9, 2025 1.1y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | AbbVie ABBV | Apr 7, 2025 32 days to disclose | Good buy·+$1.4K+17.2% +6.8% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Merck MRK Stock | Jan 15, 2025 26 days to disclose | Good buy·+$1.1K+13.5% +7.8% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Merck MRK Stock | Jan 15, 2025 26 days to disclose | Flat·+0.0% +5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Merck MRK Stock | Jan 15, 2025 26 days to disclose | Flat·+0.0% +5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | AbbVie ABBV | Jan 15, 2025 26 days to disclose | Good buy·+$2.1K+25.9% +20.2% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | AbbVie ABBV | Jan 15, 2025 26 days to disclose | Good buy·+$2.1K+25.9% +20.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 9, 2024 1.5y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Merck MRK Stock | Nov 8, 2024 31 days to disclose | Good buy·+$827+10.3% +11.5% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 9, 2024 1.5y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Johnson & Johnson JNJ | Nov 8, 2024 31 days to disclose | Good buy·+$3.9K+48.8% +49.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Johnson & Johnson JNJ | Feb 1, 2024 202 days to disclose · 157 past 45-day window | Flat·+0.0% +4.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Zoetis ZTS | Dec 28, 2023 237 days to disclose · 192 past 45-day window | Bad buy·−$4.9K-61.3% −70.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Eli Lilly LLY | Dec 28, 2023 237 days to disclose · 192 past 45-day window | Good buy·+$6.5K+81.7% +72.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Eli Lilly LLY | Sep 1, 2023 355 days to disclose · 310 past 45-day window | Good buy·+$7.2K+89.5% +78.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Merck MRK Stock | Sep 1, 2023 355 days to disclose · 310 past 45-day window | Good buy·+$450+5.6% −5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Merck MRK Stock | Jul 14, 2023 404 days to disclose · 359 past 45-day window | Good buy·+$464+5.8% −7.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Amgen AMGN | Jul 14, 2023 404 days to disclose · 359 past 45-day window | Good buy·+$3.6K+45.4% +32.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Pfizer PFE Pfizer, Inc. | Jul 14, 2023 404 days to disclose · 359 past 45-day window | Bad buy·−$2.2K-27.0% −39.7% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 19, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Zoetis ZTS | Jul 5, 2024 45 days to disclose | Flat·+0.0% +2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 6, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Zoetis ZTS | Jul 5, 2024 32 days to disclose | Flat·+0.0% +2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 6, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Zoetis ZTS | Jul 5, 2024 32 days to disclose | Flat·+0.0% +2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 6, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Johnson & Johnson JNJ | Jul 1, 2024 36 days to disclose | Good buy·+$4.6K+58.0% +55.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 22, 2024 2.4y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Pfizer PFE | Dec 28, 2023 25 days to disclose | Flat·+0.0% +9.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 22, 2024 2.4y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Eli Lilly LLY | Dec 28, 2023 25 days to disclose | Flat·+0.0% +9.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 22, 2024 2.4y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Merck MRK Stock | Dec 28, 2023 25 days to disclose | Good buy·+$352+4.4% −4.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 22, 2024 2.4y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Merck MRK Stock | Dec 28, 2023 25 days to disclose | Good buy·+$352+4.4% −4.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 22, 2024 2.4y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Pfizer PFE | Dec 28, 2023 25 days to disclose | Bad buy·−$628-7.8% −16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 10, 2023 3.2y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Merck MRK Stock | Feb 24, 2023 14 days to disclose | Good buy·+$267+3.3% −12.2% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 10, 2023 3.2y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Pfizer PFE | Feb 21, 2023 17 days to disclose | Bad buy·−$3K-37.9% −51.9% vs S&P 500 | $1K-$15K midpoint $8K |